| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |